Cervical cancer kills 4,300 American women annually. Most of these deaths are preventable. Teal Health's at-home screening ...

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...

Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...

MANDEVILLE, Manchester — The obstetrics and gynaecology department at Mandeville Regional Hospital has been gifted ...

Tisotumab vedotin plus carboplatin and pembrolizumab improved survival outcomes in patients with recurrent/metastatic cervical cancer.

Advances in precision medicine are reshaping the management of gynecologic cancers, with molecular profiling, biomarker-guided treatment selection, targeted ...

Almost 60% of patients met the primary endpoint of progression-free survival (PFS) at 6 months with the CDK4/6 inhibitor ...

Transient HPV is the norm, whereas persistent high-risk HPV over years drives cervical dysplasia and malignant transformation, supporting longitudinal surveillance when high-risk types are identified.

Aricca Wallace never thought she'd still be here. In fact, in 2012, she was told she likely had less than a year to live. Two years later, she learned it wasn't. Instead, the bleeding was caused by ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In May 2025, for the first time ever, the U.S. Food and Drug Administration granted approval ...